Stocklytics Platform
Asset logo for symbol HSDT
Helius Medical Technologies
HSDT64
$0.45arrow_drop_up7.85%$0.03
High Value
Penny Stock
Asset logo for symbol HSDT
HSDT64

$0.45

arrow_drop_up7.85%

Performance History

Chart placeholder
Key Stats
Open$0.46
Prev. Close$0.43
EPS-4.27
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$1.68M
PE Ratio-
LOWHIGH
Day Range0.40
0.56
52 Week Range0.40
9.89
Ratios
Revenue-
EBITDA Margin %-
EPS-4.27

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Helius Medical Technologies (HSDT)

Helius Medical Technologies Inc. (HSDT) is a neurotech company that develops, manufactures, and markets non-invasive brain stimulation technology. The company's flagship product is the Portable Neuromodulation Stimulator (PoNS), which is designed to deliver neurostimulation to the brain through the tongue. The PoNS device is intended to be used in conjunction with physical therapy for the treatment of balance and gait disorders in patients with neurological conditions such as multiple sclerosis and traumatic brain injury.
The history of Helius Medical Technologies dates back to 2010 when the company was founded by a group of scientists and entrepreneurs with a vision to unlock the potential of non-invasive brain stimulation. Over the years, the company has made significant advancements in the field of neurotech and has received FDA clearance for the PoNS device in 2018. This milestone has enabled the company to commercialize their innovative technology and offer a novel therapeutic option to patients suffering from balance and gait disorders.
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Dane Carl Andreeff
Headquarters
Newtown
Employees
26
Exchange
NASDAQ
add Helius Medical Technologies  to watchlist

Keep an eye on Helius Medical Technologies

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Helius Medical Technologies 's (HSDT) price per share?

The current price per share for Helius Medical Technologies (HSDT) is $0.45. The stock has seen a price change of $0.03 recently, indicating a 7.86% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Helius Medical Technologies (HSDT)?

For Helius Medical Technologies (HSDT), the 52-week high is $9.89, which is 2.08K% from the current price. The 52-week low is $0.41, the current price is 11.63% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Helius Medical Technologies (HSDT) a growth stock?

Helius Medical Technologies (HSDT) has shown an average price growth of -4.13% over the past three years. It has received a score of -5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Helius Medical Technologies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Helius Medical Technologies (HSDT) stock price performance year to date (YTD)?

As of the latest data, Helius Medical Technologies (HSDT) has a year-to-date price change of -94.4%. Over the past month, the stock has experienced a price change of -12.68%. Over the last three months, the change has been -37.92%. Over the past six months, the figure is -64.59%. Looking at a longer horizon, the five-year price change stands at -99.93%.
help

Is Helius Medical Technologies (HSDT) a profitable company?

Helius Medical Technologies (HSDT) has a net income of -$8.85M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 9.47% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.8K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $61K. Operating income is noted at -$12.43M. Furthermore, the EBITDA is -$11.83M.
help

What is the market capitalization of Helius Medical Technologies (HSDT)?

Helius Medical Technologies (HSDT) has a market capitalization of $1.69M. The average daily trading volume is 0.49, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level